Clinical Trial Update: Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of liraglutide versus a sulphonylurea, both added to metformin, in adults with type 2 diabetes during Ramadan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sulphonylurea (sulphonylurea)
• liraglutide (liraglutide)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2015-10-07